 | • レポートコード：QYR2104Z2422 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、129ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療 |
| Single User | ￥565,500 (USD3,900) | ▷ お問い合わせ |
| Multi User/Five User | ￥848,250 (USD5,850) | ▷ お問い合わせ |
| Enterprise License（同一法人内共有可） | ￥1,131,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査資料では、濾胞性リンパ腫治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（化学療法、放射線療法、モノクローナル抗体、幹細胞移植）、用途別市場規模（病院、クリニック、その他）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・濾胞性リンパ腫治療の市場動向 ・企業の競争状況、市場シェア ・濾胞性リンパ腫治療の種類別市場規模（化学療法、放射線療法、モノクローナル抗体、幹細胞移植） ・濾胞性リンパ腫治療の用途別市場規模（病院、クリニック、その他） ・濾胞性リンパ腫治療の北米市場規模2016-2027（アメリカ、カナダ） ・濾胞性リンパ腫治療のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・濾胞性リンパ腫治療のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・濾胞性リンパ腫治療の中南米市場規模2016-2027（メキシコ、ブラジル） ・濾胞性リンパ腫治療の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Boehringer Ingelheim GmbH、Bristol-Myers Squibb Company、Celgene Corporation、Celldex Therapeutics, Inc.、Celltrion, Inc.、Cellular Biomedicine Group, Inc.、Coherus BioSciences, Inc.、CTI BioPharma Corp.、Curis, Inc.、Dynavax Technologies Corporation、Eisai、EpiZyme, Inc.、F. Hoffmann-La Roche Ltd.、Genentech, Inc.、Gilead Sciences, Inc.、GlaxoSmithKline Plc、Hutchison MediPharma Limited、Immune Design Corp.、ImmunoGen, Inc.） ・結論 |
Market Analysis and Insights: Global Follicular Lymphoma Treatment Market
The global Follicular Lymphoma Treatment market size is projected to reach US$ 2526.8 million by 2026, from US$ 1620.1 million in 2019, at a CAGR of 6.5% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Follicular Lymphoma Treatment market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Follicular Lymphoma Treatment market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Follicular Lymphoma Treatment market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Follicular Lymphoma Treatment market.
Global Follicular Lymphoma Treatment Scope and Market Size
Follicular Lymphoma Treatment market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Follicular Lymphoma Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Chemotherapy
Radiotherapy
Monoclonal Antibodies
Stem Cell Transplantation
Segment by Application
Hospital
Clinic
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Boehringer Ingelheim GmbH
Bristol-Myers Squibb Company
Celgene Corporation
Celldex Therapeutics, Inc.
Celltrion, Inc.
Cellular Biomedicine Group, Inc.
Coherus BioSciences, Inc.
CTI BioPharma Corp.
Curis, Inc.
Celldex Therapeutics, Inc.
Celltrion, Inc.
EpiZyme, Inc.
F. Hoffmann-La Roche Ltd.
Genentech, Inc.
Gilead Sciences, Inc.
GlaxoSmithKline Plc
Hutchison MediPharma Limited
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Follicular Lymphoma Treatment Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Chemotherapy
1.2.3 Radiotherapy
1.2.4 Monoclonal Antibodies
1.2.5 Stem Cell Transplantation
1.3 Market by Application
1.3.1 Global Follicular Lymphoma Treatment Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Follicular Lymphoma Treatment Market Perspective (2016-2027)
2.2 Follicular Lymphoma Treatment Growth Trends by Regions
2.2.1 Follicular Lymphoma Treatment Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Follicular Lymphoma Treatment Historic Market Share by Regions (2016-2021)
2.2.3 Follicular Lymphoma Treatment Forecasted Market Size by Regions (2022-2027)
2.3 Follicular Lymphoma Treatment Industry Dynamic
2.3.1 Follicular Lymphoma Treatment Market Trends
2.3.2 Follicular Lymphoma Treatment Market Drivers
2.3.3 Follicular Lymphoma Treatment Market Challenges
2.3.4 Follicular Lymphoma Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Follicular Lymphoma Treatment Players by Revenue
3.1.1 Global Top Follicular Lymphoma Treatment Players by Revenue (2016-2021)
3.1.2 Global Follicular Lymphoma Treatment Revenue Market Share by Players (2016-2021)
3.2 Global Follicular Lymphoma Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Follicular Lymphoma Treatment Revenue
3.4 Global Follicular Lymphoma Treatment Market Concentration Ratio
3.4.1 Global Follicular Lymphoma Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Follicular Lymphoma Treatment Revenue in 2020
3.5 Follicular Lymphoma Treatment Key Players Head office and Area Served
3.6 Key Players Follicular Lymphoma Treatment Product Solution and Service
3.7 Date of Enter into Follicular Lymphoma Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Follicular Lymphoma Treatment Breakdown Data by Type
4.1 Global Follicular Lymphoma Treatment Historic Market Size by Type (2016-2021)
4.2 Global Follicular Lymphoma Treatment Forecasted Market Size by Type (2022-2027)
5 Follicular Lymphoma Treatment Breakdown Data by Application
5.1 Global Follicular Lymphoma Treatment Historic Market Size by Application (2016-2021)
5.2 Global Follicular Lymphoma Treatment Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Follicular Lymphoma Treatment Market Size (2016-2027)
6.2 North America Follicular Lymphoma Treatment Market Size by Type
6.2.1 North America Follicular Lymphoma Treatment Market Size by Type (2016-2021)
6.2.2 North America Follicular Lymphoma Treatment Market Size by Type (2022-2027)
6.2.3 North America Follicular Lymphoma Treatment Market Size by Type (2016-2027)
6.3 North America Follicular Lymphoma Treatment Market Size by Application
6.3.1 North America Follicular Lymphoma Treatment Market Size by Application (2016-2021)
6.3.2 North America Follicular Lymphoma Treatment Market Size by Application (2022-2027)
6.3.3 North America Follicular Lymphoma Treatment Market Size by Application (2016-2027)
6.4 North America Follicular Lymphoma Treatment Market Size by Country
6.4.1 North America Follicular Lymphoma Treatment Market Size by Country (2016-2021)
6.4.2 North America Follicular Lymphoma Treatment Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada
7 Europe
7.1 Europe Follicular Lymphoma Treatment Market Size (2016-2027)
7.2 Europe Follicular Lymphoma Treatment Market Size by Type
7.2.1 Europe Follicular Lymphoma Treatment Market Size by Type (2016-2021)
7.2.2 Europe Follicular Lymphoma Treatment Market Size by Type (2022-2027)
7.2.3 Europe Follicular Lymphoma Treatment Market Size by Type (2016-2027)
7.3 Europe Follicular Lymphoma Treatment Market Size by Application
7.3.1 Europe Follicular Lymphoma Treatment Market Size by Application (2016-2021)
7.3.2 Europe Follicular Lymphoma Treatment Market Size by Application (2022-2027)
7.3.3 Europe Follicular Lymphoma Treatment Market Size by Application (2016-2027)
7.4 Europe Follicular Lymphoma Treatment Market Size by Country
7.4.1 Europe Follicular Lymphoma Treatment Market Size by Country (2016-2021)
7.4.2 Europe Follicular Lymphoma Treatment Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Follicular Lymphoma Treatment Market Size (2016-2027)
8.2 Asia-Pacific Follicular Lymphoma Treatment Market Size by Type
8.2.1 Asia-Pacific Follicular Lymphoma Treatment Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Follicular Lymphoma Treatment Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Follicular Lymphoma Treatment Market Size by Type (2016-2027)
8.3 Asia-Pacific Follicular Lymphoma Treatment Market Size by Application
8.3.1 Asia-Pacific Follicular Lymphoma Treatment Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Follicular Lymphoma Treatment Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Follicular Lymphoma Treatment Market Size by Application (2016-2027)
8.4 Asia-Pacific Follicular Lymphoma Treatment Market Size by Region
8.4.1 Asia-Pacific Follicular Lymphoma Treatment Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Follicular Lymphoma Treatment Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Follicular Lymphoma Treatment Market Size (2016-2027)
9.2 Latin America Follicular Lymphoma Treatment Market Size by Type
9.2.1 Latin America Follicular Lymphoma Treatment Market Size by Type (2016-2021)
9.2.2 Latin America Follicular Lymphoma Treatment Market Size by Type (2022-2027)
9.2.3 Latin America Follicular Lymphoma Treatment Market Size by Type (2016-2027)
9.3 Latin America Follicular Lymphoma Treatment Market Size by Application
9.3.1 Latin America Follicular Lymphoma Treatment Market Size by Application (2016-2021)
9.3.2 Latin America Follicular Lymphoma Treatment Market Size by Application (2022-2027)
9.3.3 Latin America Follicular Lymphoma Treatment Market Size by Application (2016-2027)
9.4 Latin America Follicular Lymphoma Treatment Market Size by Country
9.4.1 Latin America Follicular Lymphoma Treatment Market Size by Country (2016-2021)
9.4.2 Latin America Follicular Lymphoma Treatment Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Follicular Lymphoma Treatment Market Size (2016-2027)
10.2 Middle East & Africa Follicular Lymphoma Treatment Market Size by Type
10.2.1 Middle East & Africa Follicular Lymphoma Treatment Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Follicular Lymphoma Treatment Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Follicular Lymphoma Treatment Market Size by Type (2016-2027)
10.3 Middle East & Africa Follicular Lymphoma Treatment Market Size by Application
10.3.1 Middle East & Africa Follicular Lymphoma Treatment Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Follicular Lymphoma Treatment Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Follicular Lymphoma Treatment Market Size by Application (2016-2027)
10.4 Middle East & Africa Follicular Lymphoma Treatment Market Size by Country
10.4.1 Middle East & Africa Follicular Lymphoma Treatment Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Follicular Lymphoma Treatment Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Boehringer Ingelheim GmbH
11.1.1 Boehringer Ingelheim GmbH Company Details
11.1.2 Boehringer Ingelheim GmbH Business Overview
11.1.3 Boehringer Ingelheim GmbH Follicular Lymphoma Treatment Introduction
11.1.4 Boehringer Ingelheim GmbH Revenue in Follicular Lymphoma Treatment Business (2016-2021)
11.1.5 Boehringer Ingelheim GmbH Recent Development
11.2 Bristol-Myers Squibb Company
11.2.1 Bristol-Myers Squibb Company Company Details
11.2.2 Bristol-Myers Squibb Company Business Overview
11.2.3 Bristol-Myers Squibb Company Follicular Lymphoma Treatment Introduction
11.2.4 Bristol-Myers Squibb Company Revenue in Follicular Lymphoma Treatment Business (2016-2021)
11.2.5 Bristol-Myers Squibb Company Recent Development
11.3 Celgene Corporation
11.3.1 Celgene Corporation Company Details
11.3.2 Celgene Corporation Business Overview
11.3.3 Celgene Corporation Follicular Lymphoma Treatment Introduction
11.3.4 Celgene Corporation Revenue in Follicular Lymphoma Treatment Business (2016-2021)
11.3.5 Celgene Corporation Recent Development
11.4 Celldex Therapeutics, Inc.
11.4.1 Celldex Therapeutics, Inc. Company Details
11.4.2 Celldex Therapeutics, Inc. Business Overview
11.4.3 Celldex Therapeutics, Inc. Follicular Lymphoma Treatment Introduction
11.4.4 Celldex Therapeutics, Inc. Revenue in Follicular Lymphoma Treatment Business (2016-2021)
11.4.5 Celldex Therapeutics, Inc. Recent Development
11.5 Celltrion, Inc.
11.5.1 Celltrion, Inc. Company Details
11.5.2 Celltrion, Inc. Business Overview
11.5.3 Celltrion, Inc. Follicular Lymphoma Treatment Introduction
11.5.4 Celltrion, Inc. Revenue in Follicular Lymphoma Treatment Business (2016-2021)
11.5.5 Celltrion, Inc. Recent Development
11.6 Cellular Biomedicine Group, Inc.
11.6.1 Cellular Biomedicine Group, Inc. Company Details
11.6.2 Cellular Biomedicine Group, Inc. Business Overview
11.6.3 Cellular Biomedicine Group, Inc. Follicular Lymphoma Treatment Introduction
11.6.4 Cellular Biomedicine Group, Inc. Revenue in Follicular Lymphoma Treatment Business (2016-2021)
11.6.5 Cellular Biomedicine Group, Inc. Recent Development
11.7 Coherus BioSciences, Inc.
11.7.1 Coherus BioSciences, Inc. Company Details
11.7.2 Coherus BioSciences, Inc. Business Overview
11.7.3 Coherus BioSciences, Inc. Follicular Lymphoma Treatment Introduction
11.7.4 Coherus BioSciences, Inc. Revenue in Follicular Lymphoma Treatment Business (2016-2021)
11.7.5 Coherus BioSciences, Inc. Recent Development
11.8 CTI BioPharma Corp.
11.8.1 CTI BioPharma Corp. Company Details
11.8.2 CTI BioPharma Corp. Business Overview
11.8.3 CTI BioPharma Corp. Follicular Lymphoma Treatment Introduction
11.8.4 CTI BioPharma Corp. Revenue in Follicular Lymphoma Treatment Business (2016-2021)
11.8.5 CTI BioPharma Corp. Recent Development
11.9 Curis, Inc.
11.9.1 Curis, Inc. Company Details
11.9.2 Curis, Inc. Business Overview
11.9.3 Curis, Inc. Follicular Lymphoma Treatment Introduction
11.9.4 Curis, Inc. Revenue in Follicular Lymphoma Treatment Business (2016-2021)
11.9.5 Curis, Inc. Recent Development
11.10 Dynavax Technologies Corporation
11.10.1 Dynavax Technologies Corporation Company Details
11.10.2 Dynavax Technologies Corporation Business Overview
11.10.3 Dynavax Technologies Corporation Follicular Lymphoma Treatment Introduction
11.10.4 Dynavax Technologies Corporation Revenue in Follicular Lymphoma Treatment Business (2016-2021)
11.10.5 Dynavax Technologies Corporation Recent Development
11.11 Eisai
11.11.1 Eisai Company Details
11.11.2 Eisai Business Overview
11.11.3 Eisai Follicular Lymphoma Treatment Introduction
11.11.4 Eisai Revenue in Follicular Lymphoma Treatment Business (2016-2021)
11.11.5 Eisai Recent Development
11.12 EpiZyme, Inc.
11.12.1 EpiZyme, Inc. Company Details
11.12.2 EpiZyme, Inc. Business Overview
11.12.3 EpiZyme, Inc. Follicular Lymphoma Treatment Introduction
11.12.4 EpiZyme, Inc. Revenue in Follicular Lymphoma Treatment Business (2016-2021)
11.12.5 EpiZyme, Inc. Recent Development
11.13 F. Hoffmann-La Roche Ltd.
11.13.1 F. Hoffmann-La Roche Ltd. Company Details
11.13.2 F. Hoffmann-La Roche Ltd. Business Overview
11.13.3 F. Hoffmann-La Roche Ltd. Follicular Lymphoma Treatment Introduction
11.13.4 F. Hoffmann-La Roche Ltd. Revenue in Follicular Lymphoma Treatment Business (2016-2021)
11.13.5 F. Hoffmann-La Roche Ltd. Recent Development
11.14 Genentech, Inc.
11.14.1 Genentech, Inc. Company Details
11.14.2 Genentech, Inc. Business Overview
11.14.3 Genentech, Inc. Follicular Lymphoma Treatment Introduction
11.14.4 Genentech, Inc. Revenue in Follicular Lymphoma Treatment Business (2016-2021)
11.14.5 Genentech, Inc. Recent Development
11.15 Gilead Sciences, Inc.
11.15.1 Gilead Sciences, Inc. Company Details
11.15.2 Gilead Sciences, Inc. Business Overview
11.15.3 Gilead Sciences, Inc. Follicular Lymphoma Treatment Introduction
11.15.4 Gilead Sciences, Inc. Revenue in Follicular Lymphoma Treatment Business (2016-2021)
11.15.5 Gilead Sciences, Inc. Recent Development
11.16 GlaxoSmithKline Plc
11.16.1 GlaxoSmithKline Plc Company Details
11.16.2 GlaxoSmithKline Plc Business Overview
11.16.3 GlaxoSmithKline Plc Follicular Lymphoma Treatment Introduction
11.16.4 GlaxoSmithKline Plc Revenue in Follicular Lymphoma Treatment Business (2016-2021)
11.16.5 GlaxoSmithKline Plc Recent Development
11.17 Hutchison MediPharma Limited
11.17.1 Hutchison MediPharma Limited Company Details
11.17.2 Hutchison MediPharma Limited Business Overview
11.17.3 Hutchison MediPharma Limited Follicular Lymphoma Treatment Introduction
11.17.4 Hutchison MediPharma Limited Revenue in Follicular Lymphoma Treatment Business (2016-2021)
11.17.5 Hutchison MediPharma Limited Recent Development
11.18 Immune Design Corp.
11.18.1 Immune Design Corp. Company Details
11.18.2 Immune Design Corp. Business Overview
11.18.3 Immune Design Corp. Follicular Lymphoma Treatment Introduction
11.18.4 Immune Design Corp. Revenue in Follicular Lymphoma Treatment Business (2016-2021)
11.18.5 Immune Design Corp. Recent Development
11.18 ImmunoGen, Inc.
.1 ImmunoGen, Inc. Company Details
.2 ImmunoGen, Inc. Business Overview
.3 ImmunoGen, Inc. Follicular Lymphoma Treatment Introduction
.4 ImmunoGen, Inc. Revenue in Follicular Lymphoma Treatment Business (2016-2021)
.5 ImmunoGen, Inc. Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Follicular Lymphoma Treatment Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Chemotherapy
Table 3. Key Players of Radiotherapy
Table 4. Key Players of Monoclonal Antibodies
Table 5. Key Players of Stem Cell Transplantation
Table 6. Global Follicular Lymphoma Treatment Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Follicular Lymphoma Treatment Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Follicular Lymphoma Treatment Market Size by Regions (2016-2021) & (US$ Million)
Table 9. Global Follicular Lymphoma Treatment Market Share by Regions (2016-2021)
Table 10. Global Follicular Lymphoma Treatment Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 11. Global Follicular Lymphoma Treatment Market Share by Regions (2022-2027)
Table 12. Follicular Lymphoma Treatment Market Trends
Table 13. Follicular Lymphoma Treatment Market Drivers
Table 14. Follicular Lymphoma Treatment Market Challenges
Table 15. Follicular Lymphoma Treatment Market Restraints
Table 16. Global Follicular Lymphoma Treatment Revenue by Players (2016-2021) & (US$ Million)
Table 17. Global Follicular Lymphoma Treatment Market Share by Players (2016-2021)
Table 18. Global Top Follicular Lymphoma Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Follicular Lymphoma Treatment as of 2020)
Table 19. Ranking of Global Top Follicular Lymphoma Treatment Companies by Revenue (US$ Million) in 2020
Table 20. Global 5 Largest Players Market Share by Follicular Lymphoma Treatment Revenue (CR5 and HHI) & (2016-2021)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Follicular Lymphoma Treatment Product Solution and Service
Table 23. Date of Enter into Follicular Lymphoma Treatment Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Follicular Lymphoma Treatment Market Size by Type (2016-2021) (US$ Million)
Table 26. Global Follicular Lymphoma Treatment Revenue Market Share by Type (2016-2021)
Table 27. Global Follicular Lymphoma Treatment Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 28. Global Follicular Lymphoma Treatment Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 29. Global Follicular Lymphoma Treatment Market Size Share by Application (2016-2021) & (US$ Million)
Table 30. Global Follicular Lymphoma Treatment Revenue Market Share by Application (2016-2021)
Table 31. Global Follicular Lymphoma Treatment Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 32. Global Follicular Lymphoma Treatment Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 33. North America Follicular Lymphoma Treatment Market Size by Type (2016-2021) (US$ Million)
Table 34. North America Follicular Lymphoma Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 35. North America Follicular Lymphoma Treatment Market Size by Application (2016-2021) (US$ Million)
Table 36. North America Follicular Lymphoma Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 37. North America Follicular Lymphoma Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 38. North America Follicular Lymphoma Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 39. Europe Follicular Lymphoma Treatment Market Size by Type (2016-2021) (US$ Million)
Table 40. Europe Follicular Lymphoma Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 41. Europe Follicular Lymphoma Treatment Market Size by Application (2016-2021) (US$ Million)
Table 42. Europe Follicular Lymphoma Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 43. Europe Follicular Lymphoma Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 44. Europe Follicular Lymphoma Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Follicular Lymphoma Treatment Market Size by Type (2016-2021) (US$ Million)
Table 46. Asia-Pacific Follicular Lymphoma Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Follicular Lymphoma Treatment Market Size by Application (2016-2021) (US$ Million)
Table 48. Asia-Pacific Follicular Lymphoma Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 49. Asia-Pacific Follicular Lymphoma Treatment Market Size by Region (2016-2021) & (US$ Million)
Table 50. Asia-Pacific Follicular Lymphoma Treatment Market Size by Region (2022-2027) & (US$ Million)
Table 51. Latin America Follicular Lymphoma Treatment Market Size by Type (2016-2021) (US$ Million)
Table 52. Latin America Follicular Lymphoma Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 53. Latin America Follicular Lymphoma Treatment Market Size by Application (2016-2021) (US$ Million)
Table 54. Latin America Follicular Lymphoma Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 55. Latin America Follicular Lymphoma Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 56. Latin America Follicular Lymphoma Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Follicular Lymphoma Treatment Market Size by Type (2016-2021) (US$ Million)
Table 58. Middle East & Africa Follicular Lymphoma Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Follicular Lymphoma Treatment Market Size by Application (2016-2021) (US$ Million)
Table 60. Middle East & Africa Follicular Lymphoma Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 61. Middle East & Africa Follicular Lymphoma Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 62. Middle East & Africa Follicular Lymphoma Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 63. Boehringer Ingelheim GmbH Company Details
Table 64. Boehringer Ingelheim GmbH Business Overview
Table 65. Boehringer Ingelheim GmbH Follicular Lymphoma Treatment Product
Table 66. Boehringer Ingelheim GmbH Revenue in Follicular Lymphoma Treatment Business (2016-2021) & (US$ Million)
Table 67. Boehringer Ingelheim GmbH Recent Development
Table 68. Bristol-Myers Squibb Company Company Details
Table 69. Bristol-Myers Squibb Company Business Overview
Table 70. Bristol-Myers Squibb Company Follicular Lymphoma Treatment Product
Table 71. Bristol-Myers Squibb Company Revenue in Follicular Lymphoma Treatment Business (2016-2021) & (US$ Million)
Table 72. Bristol-Myers Squibb Company Recent Development
Table 73. Celgene Corporation Company Details
Table 74. Celgene Corporation Business Overview
Table 75. Celgene Corporation Follicular Lymphoma Treatment Product
Table 76. Celgene Corporation Revenue in Follicular Lymphoma Treatment Business (2016-2021) & (US$ Million)
Table 77. Celgene Corporation Recent Development
Table 78. Celldex Therapeutics, Inc. Company Details
Table 79. Celldex Therapeutics, Inc. Business Overview
Table 80. Celldex Therapeutics, Inc. Follicular Lymphoma Treatment Product
Table 81. Celldex Therapeutics, Inc. Revenue in Follicular Lymphoma Treatment Business (2016-2021) & (US$ Million)
Table 82. Celldex Therapeutics, Inc. Recent Development
Table 83. Celltrion, Inc. Company Details
Table 84. Celltrion, Inc. Business Overview
Table 85. Celltrion, Inc. Follicular Lymphoma Treatment Product
Table 86. Celltrion, Inc. Revenue in Follicular Lymphoma Treatment Business (2016-2021) & (US$ Million)
Table 87. Celltrion, Inc. Recent Development
Table 88. Cellular Biomedicine Group, Inc. Company Details
Table 89. Cellular Biomedicine Group, Inc. Business Overview
Table 90. Cellular Biomedicine Group, Inc. Follicular Lymphoma Treatment Product
Table 91. Cellular Biomedicine Group, Inc. Revenue in Follicular Lymphoma Treatment Business (2016-2021) & (US$ Million)
Table 92. Cellular Biomedicine Group, Inc. Recent Development
Table 93. Coherus BioSciences, Inc. Company Details
Table 94. Coherus BioSciences, Inc. Business Overview
Table 95. Coherus BioSciences, Inc. Follicular Lymphoma Treatment Product
Table 96. Coherus BioSciences, Inc. Revenue in Follicular Lymphoma Treatment Business (2016-2021) & (US$ Million)
Table 97. Coherus BioSciences, Inc. Recent Development
Table 98. CTI BioPharma Corp. Company Details
Table 99. CTI BioPharma Corp. Business Overview
Table 100. CTI BioPharma Corp. Revenue in Follicular Lymphoma Treatment Business (2016-2021) & (US$ Million)
Table 101. CTI BioPharma Corp. Recent Development
Table 102. Curis, Inc. Company Details
Table 103. Curis, Inc. Business Overview
Table 104. Curis, Inc. Follicular Lymphoma Treatment Product
Table 105. Curis, Inc. Revenue in Follicular Lymphoma Treatment Business (2016-2021) & (US$ Million)
Table 106. Curis, Inc. Recent Development
Table 107. Dynavax Technologies Corporation Company Details
Table 108. Dynavax Technologies Corporation Business Overview
Table 109. Dynavax Technologies Corporation Follicular Lymphoma Treatment Product
Table 110. Dynavax Technologies Corporation Revenue in Follicular Lymphoma Treatment Business (2016-2021) & (US$ Million)
Table 111. Dynavax Technologies Corporation Recent Development
Table 112. Eisai Company Details
Table 113. Eisai Business Overview
Table 114. Eisai Follicular Lymphoma Treatment Product
Table 115. Eisai Revenue in Follicular Lymphoma Treatment Business (2016-2021) & (US$ Million)
Table 116. Eisai Recent Development
Table 117. EpiZyme, Inc. Company Details
Table 118. EpiZyme, Inc. Business Overview
Table 119. EpiZyme, Inc. Follicular Lymphoma Treatment Product
Table 120. EpiZyme, Inc. Revenue in Follicular Lymphoma Treatment Business (2016-2021) & (US$ Million)
Table 121. EpiZyme, Inc. Recent Development
Table 122. F. Hoffmann-La Roche Ltd. Company Details
Table 123. F. Hoffmann-La Roche Ltd. Business Overview
Table 124. F. Hoffmann-La Roche Ltd. Follicular Lymphoma Treatment Product
Table 125. F. Hoffmann-La Roche Ltd. Revenue in Follicular Lymphoma Treatment Business (2016-2021) & (US$ Million)
Table 126. F. Hoffmann-La Roche Ltd. Recent Development
Table 127. Genentech, Inc. Company Details
Table 128. Genentech, Inc. Business Overview
Table 129. Genentech, Inc. Follicular Lymphoma Treatment Product
Table 130. Genentech, Inc. Revenue in Follicular Lymphoma Treatment Business (2016-2021) & (US$ Million)
Table 131. Genentech, Inc. Recent Development
Table 132. Gilead Sciences, Inc. Company Details
Table 133. Gilead Sciences, Inc. Business Overview
Table 134. Gilead Sciences, Inc. Follicular Lymphoma Treatment Product
Table 135. Gilead Sciences, Inc. Revenue in Follicular Lymphoma Treatment Business (2016-2021) & (US$ Million)
Table 136. Gilead Sciences, Inc. Recent Development
Table 137. GlaxoSmithKline Plc Company Details
Table 138. GlaxoSmithKline Plc Business Overview
Table 139. GlaxoSmithKline Plc Follicular Lymphoma Treatment Product
Table 140. GlaxoSmithKline Plc Revenue in Follicular Lymphoma Treatment Business (2016-2021) & (US$ Million)
Table 141. GlaxoSmithKline Plc Recent Development
Table 142. Hutchison MediPharma Limited Company Details
Table 143. Hutchison MediPharma Limited Business Overview
Table 144. Hutchison MediPharma Limited Follicular Lymphoma Treatment Product
Table 145. Hutchison MediPharma Limited Revenue in Follicular Lymphoma Treatment Business (2016-2021) & (US$ Million)
Table 146. Hutchison MediPharma Limited Recent Development
Table 147. Immune Design Corp. Company Details
Table 148. Immune Design Corp. Business Overview
Table 149. Immune Design Corp. Follicular Lymphoma Treatment Product
Table 150. Immune Design Corp. Revenue in Follicular Lymphoma Treatment Business (2016-2021) & (US$ Million)
Table 151. Immune Design Corp. Recent Development
Table 152. ImmunoGen, Inc. Company Details
Table 153. ImmunoGen, Inc. Business Overview
Table 154. ImmunoGen, Inc. Follicular Lymphoma Treatment Product
Table 155. ImmunoGen, Inc. Revenue in Follicular Lymphoma Treatment Business (2016-2021) & (US$ Million)
Table 156. ImmunoGen, Inc. Recent Development
Table 157. Research Programs/Design for This Report
Table 158. Key Data Information from Secondary Sources
Table 159. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Follicular Lymphoma Treatment Market Share by Type: 2020 VS 2027
Figure 2. Chemotherapy Features
Figure 3. Radiotherapy Features
Figure 4. Monoclonal Antibodies Features
Figure 5. Stem Cell Transplantation Features
Figure 6. Global Follicular Lymphoma Treatment Market Share by Application: 2020 VS 2027
Figure 7. Hospital Case Studies
Figure 8. Clinic Case Studies
Figure 9. Others Case Studies
Figure 10. Follicular Lymphoma Treatment Report Years Considered
Figure 11. Global Follicular Lymphoma Treatment Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 12. Global Follicular Lymphoma Treatment Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 13. Global Follicular Lymphoma Treatment Market Share by Regions: 2020 VS 2027
Figure 14. Global Follicular Lymphoma Treatment Market Share by Regions (2022-2027)
Figure 15. Global Follicular Lymphoma Treatment Market Share by Players in 2020
Figure 16. Global Top Follicular Lymphoma Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Follicular Lymphoma Treatment as of 2020
Figure 17. The Top 10 and 5 Players Market Share by Follicular Lymphoma Treatment Revenue in 2020
Figure 18. Global Follicular Lymphoma Treatment Revenue Market Share by Type (2016-2021)
Figure 19. Global Follicular Lymphoma Treatment Revenue Market Share by Type (2022-2027)
Figure 20. North America Follicular Lymphoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 21. North America Follicular Lymphoma Treatment Market Share by Type (2016-2027)
Figure 22. North America Follicular Lymphoma Treatment Market Share by Application (2016-2027)
Figure 23. North America Follicular Lymphoma Treatment Market Share by Country (2016-2027)
Figure 24. United States Follicular Lymphoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Canada Follicular Lymphoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Follicular Lymphoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Follicular Lymphoma Treatment Market Share by Type (2016-2027)
Figure 28. Europe Follicular Lymphoma Treatment Market Share by Application (2016-2027)
Figure 29. Europe Follicular Lymphoma Treatment Market Share by Country (2016-2027)
Figure 30. Germany Follicular Lymphoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. France Follicular Lymphoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. U.K. Follicular Lymphoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Italy Follicular Lymphoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Russia Follicular Lymphoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Nordic Follicular Lymphoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Follicular Lymphoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Follicular Lymphoma Treatment Market Share by Type (2016-2027)
Figure 38. Asia-Pacific Follicular Lymphoma Treatment Market Share by Application (2016-2027)
Figure 39. Asia-Pacific Follicular Lymphoma Treatment Market Share by Region (2016-2027)
Figure 40. China Follicular Lymphoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Japan Follicular Lymphoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. South Korea Follicular Lymphoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Southeast Asia Follicular Lymphoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. India Follicular Lymphoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Australia Follicular Lymphoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Follicular Lymphoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Follicular Lymphoma Treatment Market Share by Type (2016-2027)
Figure 48. Latin America Follicular Lymphoma Treatment Market Share by Application (2016-2027)
Figure 49. Latin America Follicular Lymphoma Treatment Market Share by Country (2016-2027)
Figure 50. Mexico Follicular Lymphoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Brazil Follicular Lymphoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Follicular Lymphoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Follicular Lymphoma Treatment Market Share by Type (2016-2027)
Figure 54. Middle East & Africa Follicular Lymphoma Treatment Market Share by Application (2016-2027)
Figure 55. Middle East & Africa Follicular Lymphoma Treatment Market Share by Country (2016-2027)
Figure 56. Turkey Follicular Lymphoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Saudi Arabia Follicular Lymphoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. UAE Follicular Lymphoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. Boehringer Ingelheim GmbH Revenue Growth Rate in Follicular Lymphoma Treatment Business (2016-2021)
Figure 60. Bristol-Myers Squibb Company Revenue Growth Rate in Follicular Lymphoma Treatment Business (2016-2021)
Figure 61. Celgene Corporation Revenue Growth Rate in Follicular Lymphoma Treatment Business (2016-2021)
Figure 62. Celldex Therapeutics, Inc. Revenue Growth Rate in Follicular Lymphoma Treatment Business (2016-2021)
Figure 63. Celltrion, Inc. Revenue Growth Rate in Follicular Lymphoma Treatment Business (2016-2021)
Figure 64. Cellular Biomedicine Group, Inc. Revenue Growth Rate in Follicular Lymphoma Treatment Business (2016-2021)
Figure 65. Coherus BioSciences, Inc. Revenue Growth Rate in Follicular Lymphoma Treatment Business (2016-2021)
Figure 66. CTI BioPharma Corp. Revenue Growth Rate in Follicular Lymphoma Treatment Business (2016-2021)
Figure 67. Curis, Inc. Revenue Growth Rate in Follicular Lymphoma Treatment Business (2016-2021)
Figure 68. Dynavax Technologies Corporation Revenue Growth Rate in Follicular Lymphoma Treatment Business (2016-2021)
Figure 69. Eisai Revenue Growth Rate in Follicular Lymphoma Treatment Business (2016-2021)
Figure 70. EpiZyme, Inc. Revenue Growth Rate in Follicular Lymphoma Treatment Business (2016-2021)
Figure 71. F. Hoffmann-La Roche Ltd. Revenue Growth Rate in Follicular Lymphoma Treatment Business (2016-2021)
Figure 72. Genentech, Inc. Revenue Growth Rate in Follicular Lymphoma Treatment Business (2016-2021)
Figure 73. Gilead Sciences, Inc. Revenue Growth Rate in Follicular Lymphoma Treatment Business (2016-2021)
Figure 74. GlaxoSmithKline Plc Revenue Growth Rate in Follicular Lymphoma Treatment Business (2016-2021)
Figure 75. Hutchison MediPharma Limited Revenue Growth Rate in Follicular Lymphoma Treatment Business (2016-2021)
Figure 76. Immune Design Corp. Revenue Growth Rate in Follicular Lymphoma Treatment Business (2016-2021)
Figure 77. ImmunoGen, Inc. Revenue Growth Rate in Follicular Lymphoma Treatment Business (2016-2021)
Figure 78. Bottom-up and Top-down Approaches for This Report
Figure 79. Data Triangulation
Figure 80. Key Executives Interviewed
世界の濾胞性リンパ腫治療薬市場規模・現状・予測（2021年-2027年） Follicular lymphoma is a type of blood cancer. It is the most common of the indolent (slow-growing) non-Hodgkin's lymphomas, and the second-most-common form of non-Hodgkin's lymphomas overall. It is defined as a lymphoma of follicle center B-cells (centrocytes and centroblasts), which has at least a…- 世界のマントル細胞リンパ腫治療市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Mantle Cell Lymphoma Treatment Market The global Mantle Cell Lymphoma Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis and high data int…
- 世界のホジキンリンパ腫治療市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Hodgkin Lymphoma Treatment Market The global Hodgkin Lymphoma Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis and high data integrity, …
- 世界の犬リンパ腫治療市場規模・現状・予測（2021年-2027年） Malignant lymphoma or lymphosarcoma are one of the common tumours in canine species such as dogs accounting for approximately 7-24% of all canine tumours and 83% of all canine blood cells malignancies. Canine lymphoma treatment are drugs used in the treatment and mitigation of tumours. Market Analys…
- 世界のバーキットリンパ腫治療市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Burkitt Lymphoma Treatment Market The global Burkitt Lymphoma Treatment market size is projected to reach US$ 839.6 million by 2026, from US$ 708.4 million in 2019, at a CAGR of 2.4% during 2021-2026. With industry-standard accuracy in analysis and high data inte…